Analyse CapsoVision, Inc. (CV) — Kairos Score 68/100

À propos de CapsoVision, Inc.

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon). It also provides CapsoCloud cloud-based software-as-a-service ecosystem as an off-premises video access and download solution; CapsoView, a data access reading device for viewing capsule videos; CapsoAccess, a Capsule data access system; and CapsoRetrieve, a retrieval kit to recover the capsule using a magnetic wand, as well as capsule video reading services. The company serves gastrointestinal medical practices, clinics, and hospitals. It sells its products to distributor customers who resell products. The company was formerly known as Capso Vision Inc. and changed its name to CapsoVision, Inc. in May 2016. CapsoVision, Inc. was incorporated in 2005 and is headquartered in Saratoga, California.

Informations clés

🕴️ Activité des initiés (90 jours)

3 transactions — 3 achats et 0 ventes déclarés par les dirigeants de CapsoVision, Inc..

🏦 Hedge Funds

15 fonds institutionnels déclarent une position sur CV dans leur dernière déclaration trimestrielle SEC.

📰 Actualités récentes

15 articles récents sur CV.

• CapsoVision to Present at the 20th Annual LD Micro Main Event
• CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®

🧠 Ce qui fait Kairos Insider

Au-dela des donnees brutes, nous agregeons et scoring tout le signal smart money pour vous donner une vue unique.